Skip to main content

Advertisement

Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Phase 1 safety and tolerability study of BMP-7 in symptomatic knee osteoarthritis

  • David J Hunter1, 2Email author,
  • Marilyn C Pike3,
  • Beth L Jonas4,
  • Eugene Kissin5,
  • Julie Krop6 and
  • Tim McAlindon7
BMC Musculoskeletal Disorders201011:232

DOI: 10.1186/1471-2474-11-232

Received: 16 June 2010

Accepted: 10 October 2010

Published: 10 October 2010

Back to article

Open Peer Review reports

Pre-publication versions of this article and author comments to reviewers are available by contacting info@biomedcentral.com.

Original Submission
16 Jun 2010 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
12 Jul 2010 Reviewed Reviewer Report - Xavier Chevalier
22 Jul 2010 Reviewed Reviewer Report - Janette Furuzawa-Carballeda
26 Aug 2010 Author responded Author comments - David Hunter
Resubmission - Version 3
26 Aug 2010 Submitted Manuscript version 3
6 Sep 2010 Reviewed Reviewer Report - Janette Furuzawa-Carballeda
15 Sep 2010 Reviewed Reviewer Report - Xavier Chevalier
Resubmission - Version 4
Submitted Manuscript version 4
Publishing
10 Oct 2010 Editorially accepted
10 Oct 2010 Article published 10.1186/1471-2474-11-232

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting info@biomedcentral.com. All previous versions of the manuscript and all author responses to the reviewers are also available.

You can find further information about the peer review system here.

Authors’ Affiliations

(1)
New England Baptist Hospital, Boston. Division of Research, New England Baptist Hospital
(2)
Northern Clinical School, University of Sydney
(3)
MedPharm Consulting, Inc (*for Stryker Biotech)
(4)
Thurston Arthritis Research Center, University of North Carolina at Chapel Hill
(5)
Rheumatology Department, Boston University Medical Center
(6)
Stryker Biotech
(7)
Rheumatology Department, Tufts Medical Center

Advertisement